• 1
    Mix TC, Kazmi W, Khan S et al. Anemia: a continuing problem following kidney transplantation. Am J Transplant 2003; 3: 14261433.
  • 2
    Yorgin PD, Belson A, Sanchez J et al. Unexpectedly high prevalence of posttransplant anemia in pediatric and young adult renal transplant recipients. Am J Kidney Dis 2002; 40: 13061318.
  • 3
    Kim HC, Park SB, Han SY, Whang EA. Anemia following renal transplantation. Transplant Proc 2003; 35: 302303.
  • 4
    Mahmud SN, Aziz R, Ahmed E et al. Anemia characteristics after renal transplantation. Transplant Proc 2002; 34: 2428.
  • 5
    Hayashi T, Suzuki A, Shoji T et al. Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure. Am J Kidney Dis 2000; 35: 250256.
  • 6
    Harnett JD, Kent GM, Foley RN, Parfrey PS. Cardiac function and hematocrit level. Am J Kidney Dis 1995; 25 (Suppl. 1): S3S7.
  • 7
    Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE. Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant 1996; 11: 12771285.
  • 8
    Rigatto C, Parfrey P, Foley R, Negrijn C, Tribula C, Jeffery J. Congestive heart failure in renal transplant recipients: risk factors, outcomes, and relationship with ischemic heart disease. J Am Soc Nephrol 2002; 13: 10841090.
  • 9
    Rigatto C, Foley R, Jeffery J, Negrijn C, Tribula C, Parfrey P. Electrocardiographic left ventricular hypertrophy in renal transplant recipients: prognostic value and impact of blood pressure and anemia. J Am Soc Nephrol 2003; 14: 462468.
  • 10
    Vlahakos DV, Marathias KP, Agroyannis B, Madias NE. Posttransplant erythrocytosis. Kidney Int 2003; 63: 11871194.
  • 11
    Wickre CG, Norman DJ, Bennison A, Barry JM, Bennet WM. Postrenal transplant erythrocytosis: a review of 53 patients. Kidney Int 1983; 23: 731737.
  • 12
    Gaston RS, Julian BA, Curtis JJ. Posttransplant erythrocytosis: an enigma revisited. Am J Kidney Dis 1994; 24: 111.
  • 13
    Pearce JM, Chandrasekera CP, Ladusans EJ. Lacunar infarcts in polycythaemia with raised packed cell volumes. Br Med J (Clin Res Ed) 1983; 287: 935936.
  • 14
    Biswas M, Prakash PK, Cossburn M, Myers K, Hanna F. Life-threatening thrombotic complications of relative polycythaemia. J Intern Med 2003; 235: 481483.
  • 15
    Gupta M, Miller BA, Ahsan N et al. Expression of angiotensin II type I receptor on erythroid progenitors of patients with posttransplant erythrocytosis. Transplantation 2000; 70: 11881194.
  • 16
    Gossmann J, Kachel HG, Schoppe W, Scheuermann EH. Anemia in renal transplant recipients caused by concomitant therapy with azathioprine and angiotensin-converting enzyme inhibitors. Transplantation 1993; 56: 585589.
  • 17
    Pruijt JF, Haanen JB, Hollander AA, Den Ottolander GJ. Azathioprine-induced pure red-cell aplasia. Nephrol Dial Transplant 1996; 11: 13711373.
  • 18
    European Mycophenolate Mofetil Cooperative Study Group. Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial. Transplantation 1999; 68: 391396.
  • 19
    Vanrenterghem Y, Ponticelli C, Morales JM et al. Prevalence and management of anemia in renal transplant recipients: a European survey. Am J Transplant 2003; 3: 835845.
  • 20
    MacDonald AS. A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts. Transplantation 2001; 71: 271280.
  • 21
    World Health Organization. Nutritional anemias: report of a WHO scientific group. Geneva , Switzerland : World Health Organization; 1968.
  • 22
    Kahan BD, Knight R, Schoenberg L et al. Ten years of sirolimus therapy for human renal transplantation: The University of Texas at Houston experience. Transplant Proc 2003; 35 (Suppl. 3A): 25S34S.
  • 23
    Morelon E, Kreis H. Sirolimus therapy without calcineurin inhibitors: Necker Hospital 8-year experience. Transplant Proc 2003; 35 (Suppl. 3A): 52S57S.
  • 24
    Bouscary D, Pene F, Claessens YE et al. Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation. Blood 2003; 101: 34363443.
  • 25
    Toker A, Cantley LC. Signaling through the lipid products of phosphoinositide-3-OH kinase. Nature 1997; 387: 673676.
  • 26
    Jaster R, Bittorf T, Klinken SP, Brock J. Inhibition of proliferation but not erythroid differentiation of J2E cells by rapamycin. Biochem Pharmacol 1996; 51: 11811185.
  • 27
    Quesniaux VFJ, Wehrli S, Steiner C et al. The immunosuppressant Rapamycin blocks in vitro responses to hematopoietic cytokines and inhibits recovering but not steady-state hematopoiesis in vivo. Blood 1994; 84: 15431552.
  • 28
    Sun CH, Ward HJ, Paul WL, Koyle MA, Yanagawa N, Lee DB. Serum erythropoietin levels after renal transplantation. N Engl J Med 1989; 321: 151157.
  • 29
    Lezaic V, Biljanovi-Paunovi L, Pavlovic-Kentera V et al. Erythropoiesis after kidney transplantation: the role of erythropoietin, burst promoting activity and early erythroid progenitor cells. Eur J Med Res 2001; 6: 2732.
  • 30
    Morrone LF, Di Paolo S, Logoluso F et al. Interference of angiotensin-converting enzyme inhibitors on erythropoiesis in kidney transplant recipients: role of growth factors and cytokines. Transplantation 1997; 64: 913918.
  • 31
    Harada H, Andersen JS, Mann M, Terada N, Korsmeyer SJ. P70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD. Proc Natl Acad Sci USA 2001; 98: 96669670.
  • 32
    Miles AM, Markell MS, Daskalakis P et al. Anemia following renal transplantation: erythropoietin response and iron deficiency. Clin Transplant 1997; 11: 313315.